Search results
Brokerages Set Eli Lilly and Company (NYSE:LLY) Target Price at $728.05
ETF DAILY NEWS· 5 days agoShares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nineteen ratings firms that ...
Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential...
Eli Lilly stock climbs on gross margin beat, raised 2024 revenue outlook By Investing.com
Investing.com· 4 days agoEli Lilly & Co. (NYSE:LLY) saw its shares jump 5.4% in premarket trading Tuesday after the...
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024
San Francisco Chronicle· 4 days agoStocks that traded heavily or had substantial price changes on Tuesday: Eli Lilly, 3M...
Why Is Eli Lilly Stock Trading Higher On Tuesday? - Eli Lilly and Co (NYSE:LLY)
Benzinga· 4 days agoTuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
WSLS Newschannel 10 Roanoke· 4 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Associated Press· 4 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024
Stamford Advocate· 4 days agoStocks that traded heavily or had substantial price changes on Tuesday: Eli Lilly, 3M...
Indiana Fever lands Eli Lilly as jersey patch sponsor - Indianapolis Business Journal
Indianapolis Business Journal· 3 days agoIndianapolis-based pharmaceutical giant Eli Lilly and Co. will sponsor a patch on the shoulder of...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
AOL· 4 days ago(Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales forecast ...